Alkyl deoxyglycoside-polymyxin combinations against critical priority carbapenem-resistant gram-negative bacteria

被引:0
|
作者
de Matos, Ana M. [1 ]
Calado, Patricia [1 ]
Miranda, Monica [1 ]
Almeida, Rita [1 ]
Rauter, Amelia P. [1 ]
Oliveira, M. Conceicao [2 ]
Manageiro, Vera [3 ,4 ,5 ]
Canica, Manuela [3 ,4 ,5 ,6 ]
机构
[1] Univ Lisbon, Fac Ciencias, Ctr Quim Estrutural,Dept Quim & Bioquim, Inst Mol Sci, P-1749016 Lisbon, Portugal
[2] Inst Super Tecn, Inst Mol Sci, Ctr Quim Estrutural, Ave Rovisco Pais, P-1049001 Lisbon, Portugal
[3] Natl Inst Hlth Dr Ricardo Jorge, Dept Infect Dis, Natl Reference Lab Antibiot Resistances & Healthca, P-1649016 Lisbon, Portugal
[4] Univ Porto, Inst Agr & Agrifood Sci & Technol, Ctr Studies Anim Sci, Porto, Portugal
[5] Associate Lab Anim & Vet Sci, AL4Anim, Lisbon, Portugal
[6] Univ Lisbon, Fac Vet Med, Ctr Interdisciplinary Res Anim Hlth, CIISA, Lisbon, Portugal
关键词
ENTEROBACTER-CLOACAE; MULTIDRUG-RESISTANCE; RISK-FACTORS; NEPHROTOXICITY; EPIDEMIOLOGY; INFECTIONS; GLYCOSIDES; COLISTIN; THERAPY; POTENT;
D O I
10.1038/s41598-024-51428-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The escalating antimicrobial resistance crisis urges the development of new antibacterial treatments with innovative mechanisms of action, particularly against the critical priority carbapenem-resistant Acinetobacter baumannii (CRAB), Pseudomonas aeruginosa (CRPA) and Enterobacteriaceae (CRE). Membrane-disrupting dodecyl deoxyglycosides have been reported for their interesting phosphatidylethanolamine-associated bactericidal activity against Gram-positive strains; however, their inability to penetrate the Gram-negative outer membrane (OM) renders them useless against the most challenging pathogens. Aiming to repurpose alkyl deoxyglycosides against Gram-negative bacteria, this study investigates the antimicrobial effects of five reference compounds with different deoxygenation patterns or anomeric configurations in combination with polymyxins as adjuvants for enhanced OM permeability. The generation of the lead 4,6-dideoxy scaffold was optimized through a simultaneous dideoxygenation step and applied to the synthesis of a novel alkyl 4,6-dideoxy C-glycoside 5, herein reported for the first time. When combined with subtherapeutic colistin concentrations, most glycosides demonstrated potent antimicrobial activity against several multidrug-resistant clinical isolates of CRAB, CRE and CRPA exhibiting distinct carbapenem resistance mechanisms, together with acceptable cytotoxicity against human HEK-293T and Caco-2 cells. The novel 4,6-dideoxy C-glycoside 5 emerged as the most promising prototype structure for further development (MIC 3.1 mu g/mL when combined with colistin 0.5 mu g/mL against CRPA or 0.25 mu g/mL against several CRE and CRAB strains), highlighting the potential of C-glycosylation for an improved bioactive profile. This study is the first to show the potential of IM-targeting carbohydrate-based compounds for the treatment of infections caused by MDR Gram-negative pathogens of clinical importance.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Alkyl deoxyglycoside-polymyxin combinations against critical priority carbapenem-resistant gram-negative bacteria
    Ana M. de Matos
    Patrícia Calado
    Mónica Miranda
    Rita Almeida
    Amélia P. Rauter
    M. Conceição Oliveira
    Vera Manageiro
    Manuela Caniça
    [J]. Scientific Reports, 14
  • [2] Effectiveness of a double-carbapenem combinations against carbapenem-resistant Gram-negative bacteria
    Lu, Jiayue
    Qing, Yan
    Dong, Ning
    Liu, Congcong
    Zeng, Yu
    Sun, Qiaoling
    Shentu, Qiao
    Huang, Lixing
    Wu, Yingqian
    Zhou, Hongwei
    Shen, Zhangqi
    Zhang, Rong
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (06) : 849 - 855
  • [3] Polymyxin B adjuvants against polymyxin B- and carbapenem-resistant Gram-negative bacteria
    Salvaterra Pasquini, Joao Paulo
    Queiroz, Paula Assis
    Rodrigues do Amaral, Pedro Henrique
    da Silva, Thalita Camilo
    Souza Bonfim Mendonca, Patricia de
    Vandresen, Fabio
    Carvalho Ceolis, Joao Pedro
    de Lima Scodro, Regiane Bertin
    Caleffi-Ferracioli, Katiany Rizzieri
    Cardoso, Rosilene Fressatti
    Dias Siqueira, Vera Lucia
    [J]. FUTURE MICROBIOLOGY, 2024,
  • [4] Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria
    Bergen P.J.
    Bulman Z.P.
    Landersdorfer C.B.
    Smith N.
    Lenhard J.R.
    Bulitta J.B.
    Nation R.L.
    Li J.
    Tsuji B.T.
    [J]. Infectious Diseases and Therapy, 2015, 4 (4) : 391 - 415
  • [5] Screening for carbapenem-resistant Gram-negative bacteria
    Lee, Sang Hee
    Jeong, Seok Hoon
    Cha, Sun-Shin
    [J]. LANCET INFECTIOUS DISEASES, 2006, 6 (11): : 682 - 684
  • [6] Activity of β-lactam/taniborbactam (VNRX-5133) combinations against carbapenem-resistant Gram-negative bacteria
    Mushtaq, Shazad
    Vickers, Anna
    Doumith, Michel
    Ellington, Matthew J.
    Woodford, Neil
    Livermore, David M.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (01) : 160 - 170
  • [7] Worldwide proliferation of carbapenem-resistant gram-negative bacteria
    Kurokawa, H
    Yagi, T
    Shibata, N
    Shibayama, K
    Arakawa, Y
    [J]. LANCET, 1999, 354 (9182): : 955 - 955
  • [8] Combination therapy for carbapenem-resistant Gram-negative bacteria
    Zavascki, Alexandre P.
    Bulitta, Jurgen B.
    Landersdorfer, Cornelia B.
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2013, 11 (12) : 1333 - 1353
  • [9] Combination therapy for carbapenem-resistant Gram-negative bacteria
    Paul, Mical
    Carmeli, Yehuda
    Durante-Mangoni, Emanuele
    Mouton, Johan W.
    Tacconelli, Evelina
    Theuretzbacher, Ursula
    Mussini, Cristina
    Leibovici, Leonard
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (09) : 2305 - 2309
  • [10] Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
    Jean, Shio-Shin
    Harnod, Dorji
    Hsueh, Po-Ren
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12